MD4 CHANGES IN COST-EFFECTIVENESS OVER TIME-THE CASE OF EPOETIN ALFA FOR RENAL REPLACEMENT THERAPY PATIENTS IN THE UK
Abstract
Authors
E Remak J Hutton M Zagari
E Remak J Hutton M Zagari
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now